The threat of antimicrobial resistance (AMR) and its impact on undermining cancer treatment is a priority for UICC. Currently, knowledge and awareness of the impact of AMR on cancer outcomes within the cancer community is low. It is urgent that oncology professionals, cancer advocates, programme managers, patient groups and other stakeholders working in the field of cancer understand and address the factors that contribute to the development and spread of AMR and strategies for infection control.
In this regard, UICC will develop information to increase awareness and support the cancer community to come together and drive policy change, taking forward the WHO global action plan on antimicrobial resistance adopted by the World Health Assembly in 2015, which outlines the following five objectives:
UICC has already created a task force of experts on AMR and its impact on cancer care outcomes. The task force includes experts from the infectious diseases and cancer communities.
The task force will showcase current evidence, identify research gaps in knowledge of cancer and AMR, share best practices (please see our resources hub for more), and ultimately engage the cancer community to collaborate and bring about policy change on addressing the threat of AMR.
In the coming months, UICC and the UICC-led task force on AMR and cancer care aims to raise awareness on these issues through communications, including news and blogs, virtual learning activities, virtual dialogues, articles in science journals, and through social media channels.